ENDONOVO THERAPEUTICS, INC. Notes Issued
ENDONOVO THERAPEUTICS, INC. (ENDV) reported Notes Issued of $109.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-12-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesIssued1 · last filed 2023-12-29
- ENDONOVO THERAPEUTICS, INC. notes issued for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- ENDONOVO THERAPEUTICS, INC. notes issued for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- ENDONOVO THERAPEUTICS, INC. notes issued for the quarter ending 2023-03-31 was $109.00K, a 47.30% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. notes issued for the quarter ending 2022-12-31 was $178.00K, a 402.64% increase year-over-year.
- ENDONOVO THERAPEUTICS, INC. notes issued for fiscal 2022 was $517.00K, a 4.71% increase from fiscal 2021.
- ENDONOVO THERAPEUTICS, INC. notes issued for fiscal 2021 was $493.75K, a 66.94% decline from fiscal 2020.
- ENDONOVO THERAPEUTICS, INC. notes issued for fiscal 2020 was $1.49M, a 59.04% decline from fiscal 2019.
- ENDONOVO THERAPEUTICS, INC. notes issued for fiscal 2019 was $3.65M.
| Period end | Notes Issued 3 month | Notes Issued 6 month | Notes Issued 9 month | Notes Issued 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-29 | $0.00 derived: sum of 2 quarters · filed 2023-12-29 | $109.00K 10-Q · filed 2023-12-29 | $287.00K derived: sum of 4 quarters · filed 2023-12-29 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $109.00K 10-Q · filed 2023-08-21 | $287.00K derived: sum of 3 quarters · filed 2023-08-21 | $422.00K derived: sum of 4 quarters · filed 2023-12-29 |
| 2023-03-31 | $109.00K 10-Q · filed 2023-05-22 | $287.00K derived: sum of 2 quarters · filed 2023-05-22 | $422.00K derived: sum of 3 quarters · filed 2023-12-29 | $552.00K derived: sum of 4 quarters · filed 2023-12-29 |
| 2022-12-31 | $178.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | $313.00K derived: sum of 2 quarters · filed 2023-12-29 | $443.00K derived: sum of 3 quarters · filed 2023-12-29 | $517.00K 10-K · filed 2023-04-17 |
| 2022-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-12-29 | $265.00K derived: sum of 2 quarters · filed 2023-12-29 | $339.00K 10-Q · filed 2023-12-29 | $374.41K derived: sum of 4 quarters · filed 2023-12-29 |
| 2022-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $204.00K 10-Q · filed 2023-08-21 | $239.41K derived: sum of 3 quarters · filed 2023-08-21 | $196.12K derived: sum of 4 quarters · filed 2023-08-21 |
| 2022-03-31 | $74.00K 10-Q · filed 2023-05-22 | $109.41K derived: sum of 2 quarters · filed 2023-05-22 | $66.12K derived: sum of 3 quarters · filed 2023-05-22 | $257.70K derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | $35.41K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | -$7.88K derived: sum of 2 quarters · filed 2023-04-17 | $183.70K derived: sum of 3 quarters · filed 2023-04-17 | $493.75K 10-K · filed 2023-04-17 |
| 2021-09-30 | -$43.29K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | $148.29K derived: sum of 2 quarters · filed 2022-11-21 | $458.33K 10-Q · filed 2022-11-21 | $594.17K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $191.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $501.63K 10-Q · filed 2022-08-22 | $637.47K derived: sum of 3 quarters · filed 2022-08-22 | $683.80K derived: sum of 4 quarters · filed 2022-08-22 |
| 2021-03-31 | $310.05K 10-Q · filed 2022-05-19 | $445.89K derived: sum of 2 quarters · filed 2022-05-19 | $492.22K derived: sum of 3 quarters · filed 2022-05-19 | $753.05K derived: sum of 4 quarters · filed 2022-05-19 |
| 2020-12-31 | $135.84K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-14 | $182.17K derived: sum of 2 quarters · filed 2022-04-14 | $443.01K derived: sum of 3 quarters · filed 2022-04-14 | $1.49M 10-K · filed 2022-04-14 |
| 2020-09-30 | $46.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-19 | $307.17K derived: sum of 2 quarters · filed 2021-11-19 | $1.36M 10-Q · filed 2021-11-19 | |
| 2020-06-30 | $260.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-23 | $1.31M 10-Q · filed 2021-08-23 | ||
| 2020-03-31 | $1.05M 10-Q · filed 2021-05-24 | |||
| 2019-12-31 | $3.65M 10-K · filed 2021-04-13 |